Showing results (101-110 of 410) with videos related to
Sort By:
Pageof 41
Journal for Immunotherapy of Cancer|June 23, 2016
Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patientsVishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, et al.Cancer Immunology Research|June 1, 2023
Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint BlockadeXiaoyu Li, Jingjing Li, Yue Zheng, et al.Journal for Immunotherapy of Cancer|September 20, 2018
A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumabPhilip Friedlander, Kevin Wood, Karl Wassmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunityTaylor Sittler, Jun Zhou, Joosang Park, et al.Cancer Immunology Research|July 14, 2018
Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National CohortJ Bryan Iorgulescu, Maya Harary, Cheryl K Zogg, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor-Induced HepatitisMichael Li, Danny Wong, Jordan S Sack, et al.Cell and Tissue Banking|November 1, 2018
Separation, banking, and quality control of peripheral blood mononuclear cells from whole blood of melanoma patientsMartha Holland, Rachel Cunningham, Lake Seymour, et al.The American Journal of Surgical Pathology|June 12, 2008
Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysisDarryl A Oble, Mari Mino-Kenudson, Jeffrey Goldsmith, et al.Pigment Cell & Melanoma Research|June 19, 2025
Immunotherapy Rechallenge Is Effective for Most Patients With Late Progression After Initial Ipilimumab + Nivolumab ResponseEthan Trim, Anita Giobbie-Hurder, Tamara A Sussman, et al.Journal for Immunotherapy of Cancer|May 9, 2025
Immune checkpoint inhibitor-associated risk for venous thromboembolism: a comprehensive analysisTamara A Sussman, Anita Giobbie-Hurder, Ian D Dryg, et al.Pageof 41